Germantown, MD, United States of America

Nicholas Schaub

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Rensselaer Polytechnic Institute. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas Schaub. Retrieved from https://idiyas.com/inventor/nicholas-schaub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Nicholas Schaub

Introduction

Nicholas Schaub is an accomplished inventor based in Germantown, MD (US). He has made significant contributions to the field of pharmaceuticals through his innovative work on controlled drug release technologies. With a total of 2 patents, Schaub is recognized for his expertise in electrospun fibers.

Latest Patents

Schaub's latest patents focus on the controlled release of active pharmaceutical ingredients (APIs) from electrospun fiber scaffolds (EFSs). These inventions aim to enhance the efficacy and safety of drug delivery systems, providing a more effective means of administering medications.

Career Highlights

Nicholas Schaub is affiliated with Rensselaer Polytechnic Institute, where he continues to advance his research in drug delivery technologies. His work has garnered attention for its potential to revolutionize how medications are released in the body.

Collaborations

Schaub has collaborated with notable colleagues, including Andrew Sante Fiumara and Paul Michael Troiano. These partnerships have contributed to the development of innovative solutions in the pharmaceutical field.

Conclusion

Nicholas Schaub's contributions to controlled drug release technologies highlight his role as a leading inventor in the pharmaceutical industry. His work continues to pave the way for advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…